Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
letter
. 1995 Jan;71(831):58–59. doi: 10.1136/pgmj.71.831.58-a

The dangers of unopposed beta-adrenergic blockade in phaeochromocytoma.

R Sheaves, S L Chew, A B Grossman
PMCID: PMC2397901  PMID: 7708599

Full text

PDF
58

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beard C. M., Sheps S. G., Kurland L. T., Carney J. A., Lie J. T. Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc. 1983 Dec;58(12):802–804. [PubMed] [Google Scholar]
  2. Blodgett J., Reasner C. A. Transient thyrotoxicosis associated with a pheochromocytoma in a patient with multiple endocrine neoplasia type IIa. Am J Med. 1990 Mar;88(3):302–303. doi: 10.1016/0002-9343(90)90158-a. [DOI] [PubMed] [Google Scholar]
  3. Bouloux P. M., Perrett D. Interference of labetalol metabolites in the determination of plasma catecholamines by HPLC with electrochemical detection. Clin Chim Acta. 1985 Aug 15;150(2):111–117. doi: 10.1016/0009-8981(85)90261-x. [DOI] [PubMed] [Google Scholar]
  4. Briggs R. S., Birtwell A. J., Pohl J. E. Hypertensive response to labetalol in phaeochromocytoma. Lancet. 1978 May 13;1(8072):1045–1046. doi: 10.1016/s0140-6736(78)90772-9. [DOI] [PubMed] [Google Scholar]
  5. Calhoun D. A., Oparil S. Treatment of hypertensive crisis. N Engl J Med. 1990 Oct 25;323(17):1177–1183. doi: 10.1056/NEJM199010253231706. [DOI] [PubMed] [Google Scholar]
  6. Feek C. M., Earnshaw P. M. Hypertensive response to labetalol in phaeochromocytoma. Br Med J. 1980 Aug 2;281(6236):387–387. doi: 10.1136/bmj.281.6236.387-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Navaratnarajah M., White D. C. Labetalol and phaeochromocytoma. Br J Anaesth. 1984 Oct;56(10):1179–1179. doi: 10.1093/bja/56.10.1179. [DOI] [PubMed] [Google Scholar]
  8. Ober K. P. Pheochromocytoma in a patient with hyperthyroxinemia. Am J Med. 1991 Jan;90(1):137–138. doi: 10.1016/0002-9343(91)90529-7. [DOI] [PubMed] [Google Scholar]
  9. Prichard B. N. Combined alpha- and beta-receptor inhibition in the treatment of hypertension. Drugs. 1984;28 (Suppl 2):51–68. doi: 10.2165/00003495-198400282-00005. [DOI] [PubMed] [Google Scholar]
  10. Sever P., Beevers G., Bulpitt C., Lever A., Ramsay L., Reid J., Swales J. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. BMJ. 1993 Apr 10;306(6883):983–987. doi: 10.1136/bmj.306.6883.983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Sloand E. M., Thompson B. T. Propranolol-induced pulmonary edema and shock in a patient with pheochromocytoma. Arch Intern Med. 1984 Jan;144(1):173–174. [PubMed] [Google Scholar]
  12. Wark J. D., Larkins R. G. Pulmonary oedema after propranolol therapy in two cases of phaeochromocytoma. Br Med J. 1978 May 27;1(6124):1395–1396. doi: 10.1136/bmj.1.6124.1395-a. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES